Chapter/Section Purchase

1 Study Coverage
1.1 Irritable Bowel Syndrome with Constipation Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Irritable Bowel Syndrome with Constipation Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Lubiprostone
1.2.3 Linaclotide
1.2.4 Stimulant Laxatives
1.2.5 Osmotic Laxatives
1.2.6 Others
1.3 Market by Application
1.3.1 Global Irritable Bowel Syndrome with Constipation Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Irritable Bowel Syndrome with Constipation Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Irritable Bowel Syndrome with Constipation Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Irritable Bowel Syndrome with Constipation Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Irritable Bowel Syndrome with Constipation Drugs Sales by Region
2.4.1 Global Irritable Bowel Syndrome with Constipation Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Irritable Bowel Syndrome with Constipation Drugs by Region (2023-2028)
2.5 Global Irritable Bowel Syndrome with Constipation Drugs Revenue by Region
2.5.1 Global Irritable Bowel Syndrome with Constipation Drugs Revenue by Region (2017-2022)
2.5.2 Global Irritable Bowel Syndrome with Constipation Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Irritable Bowel Syndrome with Constipation Drugs Sales by Manufacturers
3.1.1 Global Top Irritable Bowel Syndrome with Constipation Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Irritable Bowel Syndrome with Constipation Drugs in 2021
3.2 Global Irritable Bowel Syndrome with Constipation Drugs Revenue by Manufacturers
3.2.1 Global Irritable Bowel Syndrome with Constipation Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Irritable Bowel Syndrome with Constipation Drugs Revenue in 2021
3.3 Global Irritable Bowel Syndrome with Constipation Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Irritable Bowel Syndrome with Constipation Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Irritable Bowel Syndrome with Constipation Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Irritable Bowel Syndrome with Constipation Drugs Sales by Type
4.1.1 Global Irritable Bowel Syndrome with Constipation Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Irritable Bowel Syndrome with Constipation Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Type (2017-2028)
4.2 Global Irritable Bowel Syndrome with Constipation Drugs Revenue by Type
4.2.1 Global Irritable Bowel Syndrome with Constipation Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Irritable Bowel Syndrome with Constipation Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Irritable Bowel Syndrome with Constipation Drugs Price by Type
4.3.1 Global Irritable Bowel Syndrome with Constipation Drugs Price by Type (2017-2022)
4.3.2 Global Irritable Bowel Syndrome with Constipation Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Irritable Bowel Syndrome with Constipation Drugs Sales by Application
5.1.1 Global Irritable Bowel Syndrome with Constipation Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Irritable Bowel Syndrome with Constipation Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Irritable Bowel Syndrome with Constipation Drugs Sales Market Share by Application (2017-2028)
5.2 Global Irritable Bowel Syndrome with Constipation Drugs Revenue by Application
5.2.1 Global Irritable Bowel Syndrome with Constipation Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Irritable Bowel Syndrome with Constipation Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Irritable Bowel Syndrome with Constipation Drugs Price by Application
5.3.1 Global Irritable Bowel Syndrome with Constipation Drugs Price by Application (2017-2022)
5.3.2 Global Irritable Bowel Syndrome with Constipation Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Irritable Bowel Syndrome with Constipation Drugs Market Size by Type
6.1.1 North America Irritable Bowel Syndrome with Constipation Drugs Sales by Type (2017-2028)
6.1.2 North America Irritable Bowel Syndrome with Constipation Drugs Revenue by Type (2017-2028)
6.2 North America Irritable Bowel Syndrome with Constipation Drugs Market Size by Application
6.2.1 North America Irritable Bowel Syndrome with Constipation Drugs Sales by Application (2017-2028)
6.2.2 North America Irritable Bowel Syndrome with Constipation Drugs Revenue by Application (2017-2028)
6.3 North America Irritable Bowel Syndrome with Constipation Drugs Market Size by Country
6.3.1 North America Irritable Bowel Syndrome with Constipation Drugs Sales by Country (2017-2028)
6.3.2 North America Irritable Bowel Syndrome with Constipation Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Irritable Bowel Syndrome with Constipation Drugs Market Size by Type
7.1.1 Europe Irritable Bowel Syndrome with Constipation Drugs Sales by Type (2017-2028)
7.1.2 Europe Irritable Bowel Syndrome with Constipation Drugs Revenue by Type (2017-2028)
7.2 Europe Irritable Bowel Syndrome with Constipation Drugs Market Size by Application
7.2.1 Europe Irritable Bowel Syndrome with Constipation Drugs Sales by Application (2017-2028)
7.2.2 Europe Irritable Bowel Syndrome with Constipation Drugs Revenue by Application (2017-2028)
7.3 Europe Irritable Bowel Syndrome with Constipation Drugs Market Size by Country
7.3.1 Europe Irritable Bowel Syndrome with Constipation Drugs Sales by Country (2017-2028)
7.3.2 Europe Irritable Bowel Syndrome with Constipation Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Irritable Bowel Syndrome with Constipation Drugs Market Size by Type
8.1.1 Asia Pacific Irritable Bowel Syndrome with Constipation Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Irritable Bowel Syndrome with Constipation Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Irritable Bowel Syndrome with Constipation Drugs Market Size by Application
8.2.1 Asia Pacific Irritable Bowel Syndrome with Constipation Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Irritable Bowel Syndrome with Constipation Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Irritable Bowel Syndrome with Constipation Drugs Market Size by Region
8.3.1 Asia Pacific Irritable Bowel Syndrome with Constipation Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Irritable Bowel Syndrome with Constipation Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Irritable Bowel Syndrome with Constipation Drugs Market Size by Type
9.1.1 Latin America Irritable Bowel Syndrome with Constipation Drugs Sales by Type (2017-2028)
9.1.2 Latin America Irritable Bowel Syndrome with Constipation Drugs Revenue by Type (2017-2028)
9.2 Latin America Irritable Bowel Syndrome with Constipation Drugs Market Size by Application
9.2.1 Latin America Irritable Bowel Syndrome with Constipation Drugs Sales by Application (2017-2028)
9.2.2 Latin America Irritable Bowel Syndrome with Constipation Drugs Revenue by Application (2017-2028)
9.3 Latin America Irritable Bowel Syndrome with Constipation Drugs Market Size by Country
9.3.1 Latin America Irritable Bowel Syndrome with Constipation Drugs Sales by Country (2017-2028)
9.3.2 Latin America Irritable Bowel Syndrome with Constipation Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Irritable Bowel Syndrome with Constipation Drugs Market Size by Type
10.1.1 Middle East and Africa Irritable Bowel Syndrome with Constipation Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Irritable Bowel Syndrome with Constipation Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Irritable Bowel Syndrome with Constipation Drugs Market Size by Application
10.2.1 Middle East and Africa Irritable Bowel Syndrome with Constipation Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Irritable Bowel Syndrome with Constipation Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Irritable Bowel Syndrome with Constipation Drugs Market Size by Country
10.3.1 Middle East and Africa Irritable Bowel Syndrome with Constipation Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Irritable Bowel Syndrome with Constipation Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Nestle
11.1.1 Nestle Corporation Information
11.1.2 Nestle Overview
11.1.3 Nestle Irritable Bowel Syndrome with Constipation Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Nestle Irritable Bowel Syndrome with Constipation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Nestle Recent Developments
11.2 Abbot Laboratories
11.2.1 Abbot Laboratories Corporation Information
11.2.2 Abbot Laboratories Overview
11.2.3 Abbot Laboratories Irritable Bowel Syndrome with Constipation Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Abbot Laboratories Irritable Bowel Syndrome with Constipation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Abbot Laboratories Recent Developments
11.3 Synergy Pharmaceuticals
11.3.1 Synergy Pharmaceuticals Corporation Information
11.3.2 Synergy Pharmaceuticals Overview
11.3.3 Synergy Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Synergy Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Synergy Pharmaceuticals Recent Developments
11.4 Sucampo Pharmaceuticals
11.4.1 Sucampo Pharmaceuticals Corporation Information
11.4.2 Sucampo Pharmaceuticals Overview
11.4.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sucampo Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sucampo Pharmaceuticals Recent Developments
11.5 Novartis
11.5.1 Novartis Corporation Information
11.5.2 Novartis Overview
11.5.3 Novartis Irritable Bowel Syndrome with Constipation Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Novartis Irritable Bowel Syndrome with Constipation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novartis Recent Developments
11.6 Astellas Pharmaceuticals
11.6.1 Astellas Pharmaceuticals Corporation Information
11.6.2 Astellas Pharmaceuticals Overview
11.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Astellas Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Astellas Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Irritable Bowel Syndrome with Constipation Drugs Industry Chain Analysis
12.2 Irritable Bowel Syndrome with Constipation Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Irritable Bowel Syndrome with Constipation Drugs Production Mode & Process
12.4 Irritable Bowel Syndrome with Constipation Drugs Sales and Marketing
12.4.1 Irritable Bowel Syndrome with Constipation Drugs Sales Channels
12.4.2 Irritable Bowel Syndrome with Constipation Drugs Distributors
12.5 Irritable Bowel Syndrome with Constipation Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Irritable Bowel Syndrome with Constipation Drugs Industry Trends
13.2 Irritable Bowel Syndrome with Constipation Drugs Market Drivers
13.3 Irritable Bowel Syndrome with Constipation Drugs Market Challenges
13.4 Irritable Bowel Syndrome with Constipation Drugs Market Restraints
14 Key Findings in The Global Irritable Bowel Syndrome with Constipation Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer